RSV shot for moms: does it shield newborns?
NCT ID NCT07122661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks how well the RSV vaccine (ABRYSVO) works when given to pregnant women to protect their babies from severe RSV illness. Researchers will look at health records of infants hospitalized with breathing problems in Australia. They want to see if vaccinated moms' babies are less likely to end up in the hospital with RSV.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABRYSVO (RSVpreF vaccine)
- What this could lead to
- If successful, this study could confirm that vaccinating pregnant women helps prevent serious RSV lung infections in newborns.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less certain. It only looks at data from one country and may not apply everywhere.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY ILLNESS (ARI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer
Sydney, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot, two viruses? new mRNA vaccine targets RSV and hMPV
- New mRNA vaccine aims to shield against RSV
- Could a vaccine given during pregnancy shield infants from a deadly virus?
- Massive RSV vaccine study uses real-world data to see if shots prevent severe illness
- New RSV vaccine aims to shield adults from severe respiratory infection
- Simple blood test could slash antibiotic overuse for coughs and colds